BioCorRx (BICX) Receivables (2010 - 2026)
BioCorRx (BICX) recorded Receivables of $170,307 in Q2 2026, down 16.9% from $204,970 a year earlier and down 78.2% from the prior quarter.
Powered by 
Analysis
BioCorRx (BICX) Receivables (2010 - 2026) Analysis & Trends
At the end of FY2025, BioCorRx reported Receivables of $305,485.
- Annual Receivables has a five-year compound annual growth rate of 173.4% (FY2020 to FY2025).
- Across earlier years, Receivables came in at $740.00 in FY2024 (-99.0%), $77,006 in FY2023 (-51.3%), $158,030 in FY2022 (+173.1%) and $57,859 in FY2021.
- The Q2 2026 figure is the lowest quarterly Receivables since Q2 2024.
- On a year-over-year basis, Receivables rose in three of the last four quarters, with growth averaging 117.3%.
- Peak year-over-year performance for Receivables in the last five years was growth of 864.3% in Q2 2022, against a decline of 98.8% in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $782,416 (Q1 2026), $305,485 (Q4 2025) and $955,957 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 12.49 Bn |
| 10 | BioCorRx | 4.32 Mn | 3.66 Mn | - | 170,307.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 170,307.00 |
| Mar 31, 2026 | 782,416.00 |
| Dec 31, 2025 | 305,485.00 |
| Sep 30, 2025 | 955,957.00 |
| Jun 30, 2025 | 204,970.00 |
| Mar 31, 2025 | 265,326.00 |
| Sep 30, 2024 | 314,170.00 |
| Jun 30, 2024 | 109,736.00 |
| Mar 31, 2024 | 21,042.00 |
| Dec 31, 2023 | 77,006.00 |
| Sep 30, 2023 | 17,206.00 |
| Jun 30, 2023 | 105,079.00 |
| Mar 31, 2023 | 83,994.00 |
| Dec 31, 2022 | 158,030.00 |
| Sep 30, 2022 | 68,192.00 |
| Jun 30, 2022 | 14,465.00 |
| Mar 31, 2022 | 11,893.00 |
| Dec 31, 2021 | 57,859.00 |
| Sep 30, 2021 | 1,500.00 |
| Jun 30, 2021 | 1,500.00 |
API Access
BioCorRx Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=BICX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "BICX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=BICX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();